Rithm Capital (RITM) vs Sabra Health Care REIT (SBRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sabra Health Care REIT (SBRA) has outperformed Rithm Capital (RITM) over the past year, gaining 4.1% versus a loss of 21.6%. Over five years, SBRA leads with a +23.2% price change compared with -24.6% for RITM. Sabra Health Care REIT is the larger company by market cap ($4.83 billion vs $4.79 billion), about 1.0 times the size.
On valuation, Rithm Capital trades at a lower forward P/E (3.7x vs 23.3x for Sabra Health Care REIT). Rithm Capital offers the higher dividend yield (11.66% vs 6.35%). Sabra Health Care REIT converts more of its revenue into profit, with a net margin of 20.1% versus 15.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RITM | SBRA |
|---|---|---|
| Share price | $8.58 | $18.91 |
| Market cap | $4.79B | $4.83B |
| 1-day change | +0.59% | +0.91% |
| YTD return | -21.74% | -1.06% |
| 1-year return | -21.60% | +4.05% |
| 5-year return | -24.65% | +23.21% |
| P/E ratio (TTM) | 14.30 | 75.64 |
| Forward P/E | 3.66 | 23.35 |
| EPS (TTM) | $0.60 | $0.25 |
| Dividend yield | 11.66% | 6.35% |
| Annual dividend | $1.00 | $1.20 |
| Revenue (latest FY) | $4.59B | $774.63M |
| Revenue growth (YoY) | -6.66% | +10.15% |
| Net income (latest FY) | $697.06M | $155.61M |
| Net margin | 15.19% | 20.09% |
| 52-week high | $12.15 | $22.77 |
| 52-week low | $8.40 | $17.17 |
| Distance from 52-week high | -29.38% | -16.95% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +52.68% | +20.52% |
| Average volume | 5.81M | 2.63M |
| Shares outstanding | 558.41M | 255.46M |
| Employees | 7,240 | 58 |
| Sector | Real Estate | Real Estate |
| Industry | Real Estate Investment Trusts | Real Estate Investment Trusts |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SBRA has outperformed RITM by 25.7 percentage points over the past year.
- Sabra Health Care REIT trades at a higher earnings multiple (75.6x vs 14.3x trailing P/E).
- Rithm Capital offers a meaningfully higher dividend yield (11.66% vs 6.35%).
- Sabra Health Care REIT grew revenue faster in its latest fiscal year (+10.15% vs -6.66%).
About Rithm Capital
RITM stock →Rithm Capital Corp. operates as an asset manager focused on real estate, credit, and financial services in the United States.
Real Estate · Real Estate Investment Trusts · 7,240 employees
About Sabra Health Care REIT
SBRA stock →Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
Real Estate · Real Estate Investment Trusts · 58 employees
RITM vs SBRA FAQ
Which is bigger, Rithm Capital or Sabra Health Care REIT?
Sabra Health Care REIT (SBRA) is larger, with a market capitalization of $4.83B compared with $4.79B for Rithm Capital (RITM).
Which stock has performed better over the past year, RITM or SBRA?
SBRA returned +4.05% over the past 12 months, compared with -21.60% for RITM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, RITM or SBRA?
RITM has the lower trailing P/E at 14.3, versus 75.6 for SBRA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Rithm Capital or Sabra Health Care REIT?
Rithm Capital has the higher yield at 11.66%, compared with 6.35% for Sabra Health Care REIT.
Are Rithm Capital and Sabra Health Care REIT in the same industry?
Yes. Both are classified in the Real Estate Investment Trusts industry within the Real Estate sector.